Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;71(6):720-725.
doi: 10.1097/MPG.0000000000002894.

Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation

Affiliations
Review

Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation

Renee Proost et al. J Pediatr Gastroenterol Nutr. 2020 Dec.

Abstract

Objectives: Since 2005, a New Wilson Index (NWI) ≥11 is used as a predictor of death without transplantation in fulminant Wilson disease (WD). Plasma exchange is advocated as a new treatment modality.

Methods: We present a patient with fulminant WD treated with plasma exchange. All published cases applying plasma exchange for fulminant WD were reviewed systematically.

Results: A 14-year-old girl presented with hemolysis and fulminant liver failure. She had no encephalopathy; NWI was 14. As a bridge to transplantation plasma exchange was started immediately. Complete remission was achieved with plasma exchange and later chelation therapy with D-penicillamine. She is now at 3-year transplant-free survival. Literature review identified 37 patients presenting with fulminant WD and NWI ≥11 who were treated with plasma exchange. Seventeen of these patients (ie, 46%) recovered without transplantation.

Conclusions: Multiple case reports and case series demonstrate transplant free survival after plasma exchange and subsequent chelation therapy, despite a NWI ≥11. Plasma exchange affects the clinical course and is a therapeutic option in children and young adults presenting with fulminant WD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sandahl TD, Laursen TL, Munk DE, et al. The prevalence of Wilson's disease: an update. Hepatology 2020; 71:722–732.
    1. Roberts EA, Schilsky ML. American Association for Study of Liver Diseases (AASLD)Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089–2111.
    1. Socha P, Janczyk W, Dhawan A, et al. Wilson's disease in children: a position paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66:334–344.
    1. Rukunuzzaman M. Wilson's disease in Bangladeshi children: analysis of 100 cases. Pediatr Gastroenterol Hepatol Nutr 2015; 18:121–127.
    1. Walshe JM. The acute haemolytic syndrome in Wilson's disease—a review of 22 patients. QJM 2013; 106:1003–1008.